Veeva Announces EDC and eSource to Transform Clinical Data Management

Go back to Veeva Announces EDC and eSource to Transform Clinical Data Management

Needham & Company Reiterates Buy on Veeva Systems (VEEV) Following New Product Announcement

October 14, 2016 6:53 AM EDT

Needham & Company reiterated a Buy rating and $46.00 price target on Veeva Systems (NYSE: VEEV) following the company's announced new products. Needham believes that the new Electronic Data Capture (EDC) and Vault eSource applications deepen the company's R&D platform, and expand TAM by $2B.

Analyst Scott... More